AUPHAurinia Pharmaceuticals Inc.
16.65USD-3.59%Mkt Cap: 2.22B $P/E: 7.303d ago
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYN…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.22B $
Enterprise Value1.84B $
Revenue (TTM)311.51M $
Gross Profit250.39M $
Net Income (TTM)287.20M $
Revenue/Share2.368 USD
Last Price16.65 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees128
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCA05156V1022
Valuation
P/E (Trailing)7.30
P/E (Forward)15.61
PEG—
EV/EBITDA10.21
EV/Revenue5.90
P/S7.11
P/B3.60
EPS (TTM)2.28
EPS (Forward)1.07
52W Range
16.604% of range17.79
52W High17.79 USD
52W Low16.60 USD
Profitability
Gross Margin88.46%
Oper. Margin55.68%
EBITDA Margin57.73%
Profit Margin101.47%
ROE49.40%
ROA38.21%
Growth
Revenue Growth18.90%
Earnings Growth75.50%
Cash Flow & Leverage
Operating CF135.66M $
CapEx (TTM)252.00K $
FCF Margin47.45%
FCF Yield6.67%
Net Debt-378.89M $
Net Debt/EBITDA-2.11
Balance Sheet
Debt/Equity0.13
Current Ratio5.42
Quick Ratio4.86
Book Value/Sh4.626 USD
Cash/Share3.330 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.86 USD
Upside (mean)+7.3%
Target Range16.00 USD – 21.00 USD
$16.00+7.3% to mean$21.00
# Analysts7
Ownership
Shares Out.133.05M
Float128.82M
Insiders7.28%
Institutions60.39%
Short Interest
Short Ratio7.0d
Short % Float7.91%
Short % Out.7.17%
Shares Short9.53M
Short (prev mo.)9.59M
Technical
SMA 5015.94 (+4.4%)
SMA 20015.42 (+8.0%)
Beta1.40
S&P 52W Chg19.18%
Avg Vol (30d)1.92M
Avg Vol (10d)1.23M
Technical Indicators
RSI (14)59.3
MACD0.1678
MACD Signal-0.0329
MACD Hist.+0.2006
BB Upper16.77 USD
BB Middle15.48 USD
BB Lower14.18 USD
BB Width16.79%
ATR (14)0.6574 USD
Vol Ratio (20d)0.98x